Home LiteratureArticle Details
PMID: 3280975 Published · ppublish English Journal Article

An oligomer complementary to c-myc mRNA inhibits proliferation of HL-60 promyelocytic cells and induces differentiation.

Molecular and cellular biology ·Vol. 8 ·No. 2 ·1988-02-00 ·Pages 963-73

Holt JT, Redner RL, Nienhuis AW

Abstract

To study the role of a nuclear proto-oncogene in the regulation of cell growth and differentiation, we inhibited HL-60 c-myc expression with a complementary antisense oligomer. This oligomer was stable in culture and entered cells, forming an intracellular duplex. Incubation of cells with the anti-myc oligomer decreased the steady-state levels of c-myc protein by 50 to 80%, whereas a control oligomer did not significantly affect the c-myc protein concentration. Direct inhibition of c-myc expression with the anti-myc oligomer was associated with a decreased cell growth rate and an induction of myeloid differentiation. Related antisense oligomers with 2- to 12-base-pair mismatches with c-myc mRNA did not influence HL-60 cells. Thus, the effects of the antisense oligomer exhibited sequence specificity, and furthermore, these effects could be reversed by hybridization competition with another complementary oligomer. Antisense inhibition of a nuclear proto-oncogene apparently bypasses cell surface events in affecting cell proliferation and differentiation.

MeSH Terms
Base Sequence Cell Differentiation Cell Division Cell Line Exons Humans Leukemia, Myeloid, Acute Molecular Sequence Data Nucleic Acid Hybridization Oligodeoxyribonucleotides/chemical synthesis,isolation & purification Proto-Oncogene Mas Proto-Oncogene Proteins/analysis,genetics Proto-Oncogenes RNA, Messenger/genetics
Chemicals
MAS1 protein, human Oligodeoxyribonucleotides Proto-Oncogene Mas Proto-Oncogene Proteins RNA, Messenger
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Holt J T
Clinical Hematology Branch, National Heart, Lung, and Blood Institute, Bethesda, Maryland 20892.
Redner R L
Nienhuis A W
References (58)
58 references, click to expand
  1. Quantitative nitroblue tetrazolium test in chronic granulomatous disease.
    N Engl J Med. 1968 May 2;278(18):971-6 PMID: 4384563
  2. Localization of actin in mammalian spermatozoa: a comparison of eight species.
    Anat Rec. 1986 Dec;216(4):504-15 PMID: 2432804
  3. Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide.
    Proc Natl Acad Sci U S A. 1978 Jan;75(1):280-4 PMID: 75545
  4. Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds.
    Proc Natl Acad Sci U S A. 1978 May;75(5):2458-62 PMID: 276884
  5. Cell cycle analysis by flow cytometry.
    Methods Enzymol. 1979;58:233-48 PMID: 423764
  6. Induction of differentiation in human promyelocytic leukemia cells by tumor promoters.
    Science. 1979 May 25;204(4395):868-70 PMID: 286421
  7. Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia.
    Blood. 1979 Sep;54(3):713-33 PMID: 288488
  8. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid.
    Proc Natl Acad Sci U S A. 1980 May;77(5):2936-40 PMID: 6930676
  9. Expression of cellular homologues of retroviral onc genes in human hematopoietic cells.
    Proc Natl Acad Sci U S A. 1982 Apr;79(8):2490-4 PMID: 6283530
  10. Amplification of endogenous myc-related DNA sequences in a human myeloid leukaemia cell line.
    Nature. 1982 Aug 12;298(5875):679-81 PMID: 6285209
  11. Onc gene amplification in promyelocytic leukaemia cell line HL-60 and primary leukaemic cells of the same patient.
    Nature. 1982 Sep 2;299(5878):61-3 PMID: 6955596
  12. RNA processing errors in patients with beta-thalassemia.
    Proc Natl Acad Sci U S A. 1982 Aug;79(15):4775-9 PMID: 6956887
  13. Specific chromosomal translocations and the genesis of B-cell-derived tumors in mice and men.
    Cell. 1983 Feb;32(2):311-5 PMID: 6402307
  14. The HL-60 transforming sequence: a ras oncogene coexisting with altered myc genes in hematopoietic tumors.
    Cell. 1983 Jul;33(3):749-57 PMID: 6683594
  15. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes.
    Nature. 1983 Aug 18-24;304(5927):596-602 PMID: 6308472
  16. Regulation of myc gene expression in HL-60 leukaemia cells by a vitamin D metabolite.
    Nature. 1983 Dec 1-7;306(5942):492-4 PMID: 6689055
  17. Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes.
    Cell. 1984 Oct;38(3):627-37 PMID: 6488314
  18. Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation.
    Nature. 1984 Dec 13-19;312(5995):649-51 PMID: 6390217
  19. Cellular immortalization by a cDNA clone encoding the transformation-associated phosphoprotein p53.
    Nature. 1984 Dec 13-19;312(5995):651-4 PMID: 6095117
  20. Control of HL-60 myeloid differentiation. Evidence of uncoupled growth and differentiation control, S-phase specificity, and two-step regulation.
    Exp Cell Res. 1985 Jan;156(1):198-212 PMID: 3855294
  21. Proteins encoded by the human c-myc oncogene: differential expression in neoplastic cells.
    Mol Cell Biol. 1984 Nov;4(11):2486-97 PMID: 6513926
  22. Relationship of c-myc expression to differentiation and proliferation of HL-60 cells.
    Cancer Res. 1985 Feb;45(2):822-5 PMID: 3855381
  23. Transcriptional regulation of c-myc during chemically induced differentiation of HL-60 cultures.
    Cancer Res. 1985 Feb;45(2):847-50 PMID: 2578312
  24. Injected anti-sense RNAs specifically block messenger RNA translation in vivo.
    Proc Natl Acad Sci U S A. 1985 Jan;82(1):144-8 PMID: 3855537
  25. Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells.
    Proc Natl Acad Sci U S A. 1985 Feb;82(3):790-4 PMID: 2858093
  26. Levels of c-myc oncogene mRNA are invariant throughout the cell cycle.
    Nature. 1985 Mar 28-Apr 3;314(6009):363-6 PMID: 3982504
  27. c-myc oncogene protein synthesis is independent of the cell cycle in human and avian cells.
    Nature. 1985 Mar 28-Apr 3;314(6009):366-9 PMID: 3885045
  28. Human N-myc gene contributes to neoplastic transformation of mammalian cells in culture.
    Nature. 1985 Jul 11-17;316(6024):160-2 PMID: 4040214
  29. Stable reduction of thymidine kinase activity in cells expressing high levels of anti-sense RNA.
    Cell. 1985 Aug;42(1):129-38 PMID: 2410135
  30. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice.
    Nature. 1985 Dec 12-18;318(6046):533-8 PMID: 3906410
  31. Studies on the interaction of the human c-myc protein with cell nuclei: p62c-myc as a member of a discrete subset of nuclear proteins.
    Cell. 1985 Nov;43(1):253-61 PMID: 3907852
  32. Specific inhibition of mRNA translation by complementary oligonucleotides covalently linked to intercalating agents.
    Proc Natl Acad Sci U S A. 1986 Mar;83(5):1227-31 PMID: 3513172
  33. Constitutive c-myc oncogene expression blocks mouse erythroleukaemia cell differentiation but not commitment.
    Nature. 1986 Apr 24-30;320(6064):760-3 PMID: 3458027
  34. Antiviral effect of an oligo(nucleoside methylphosphonate) complementary to the splice junction of herpes simplex virus type 1 immediate early pre-mRNAs 4 and 5.
    Proc Natl Acad Sci U S A. 1986 May;83(9):2787-91 PMID: 3010316
  35. Consequences of widespread deregulation of the c-myc gene in transgenic mice: multiple neoplasms and normal development.
    Cell. 1986 May 23;45(4):485-95 PMID: 3011271
  36. Inhibition of replication and expression of human T-cell lymphotropic virus type III in cultured cells by exogenous synthetic oligonucleotides complementary to viral RNA.
    Proc Natl Acad Sci U S A. 1986 Jun;83(12):4143-6 PMID: 3012555
  37. Inducible production of c-fos antisense RNA inhibits 3T3 cell proliferation.
    Proc Natl Acad Sci U S A. 1986 Jul;83(13):4794-8 PMID: 3523478
  38. The role of antisense RNA in gene regulation.
    Annu Rev Biochem. 1986;55:569-97 PMID: 2427015
  39. Expression of a transfected human c-myc oncogene inhibits differentiation of a mouse erythroleukaemia cell line.
    Nature. 1986 Aug 21-27;322(6081):748-50 PMID: 3528861
  40. Deregulated expression of c-myc by murine erythroleukaemia cells prevents differentiation.
    Nature. 1986 Aug 28-Sep 3;322(6082):848-50 PMID: 3528863
  41. Transfection of mouse erythroleukemia cells with myc sequences changes the rate of induced commitment to differentiate.
    Proc Natl Acad Sci U S A. 1986 Sep;83(17):6480-4 PMID: 3529085
  42. The c-myc oncogene perturbs B lymphocyte development in E-mu-myc transgenic mice.
    Cell. 1986 Oct 10;47(1):11-8 PMID: 3093082
  43. Oligodeoxynucleotide stability in subcellular extracts and culture media.
    J Biochem Biophys Methods. 1986 Sep;13(2):97-102 PMID: 3772027
  44. The myc oncogene: its role in transformation and differentiation.
    Annu Rev Genet. 1986;20:361-84 PMID: 3028245
  45. Analysis of polyomavirus middle-T-antigen-transformed rat cell variants expressing different levels of pp60c-src.
    J Virol. 1987 Apr;61(4):1079-85 PMID: 2434664
  46. Deregulated c-fos expression interferes with normal bone development in transgenic mice.
    Nature. 1987 Jan 29-Feb 4;325(6103):412-6 PMID: 3027573
  47. Specific antiviral activity of a poly(L-lysine)-conjugated oligodeoxyribonucleotide sequence complementary to vesicular stomatitis virus N protein mRNA initiation site.
    Proc Natl Acad Sci U S A. 1987 Feb;84(3):648-52 PMID: 3027696
  48. Antisense RNA of proto-oncogene c-fos blocks renewed growth of quiescent 3T3 cells.
    Mol Cell Biol. 1987 Feb;7(2):639-49 PMID: 3547078
  49. Autonomous expression of c-myc in BC3H1 cells partially inhibits but does not prevent myogenic differentiation.
    Mol Cell Biol. 1987 May;7(5):1973-7 PMID: 3299056
  50. A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1.
    Nature. 1987 Jul 30-Aug 5;328(6129):445-9 PMID: 3302722
  51. Transcriptional control of the endogenous MYC protooncogene by antisense RNA.
    Proc Natl Acad Sci U S A. 1987 Nov;84(21):7363-7 PMID: 2444981
  52. Transcriptional and posttranscriptional control of c-myc during myogenesis: its mRNA remains inducible in differentiated cells and does not suppress the differentiated phenotype.
    Mol Cell Biol. 1986 May;6(5):1412-21 PMID: 2431278
  53. Regulation of pp60c-src synthesis by inducible RNA complementary to c-src mRNA in polyomavirus-transformed rat cells.
    Mol Cell Biol. 1986 Jul;6(7):2305-16 PMID: 2431289
  54. c-myc and c-fos expression in differentiating mouse primary keratinocytes.
    EMBO J. 1986 Nov;5(11):2853-7 PMID: 2431900
  55. Intragenic pausing and anti-sense transcription within the murine c-myc locus.
    EMBO J. 1986 Nov;5(11):2859-65 PMID: 3024965
  56. Phorbol ester-induced growth arrest of murine myelomonocytic leukemic cells with virus-disrupted myb locus is not accompanied by decreased myc and myb expression.
    Proc Natl Acad Sci U S A. 1987 Jan;84(1):199-203 PMID: 3025854
  57. The molecular genetics of cancer.
    Science. 1987 Jan 16;235(4786):305-11 PMID: 3541204
  58. Cytochemical identification of monocytes and granulocytes.
    Am J Clin Pathol. 1971 Mar;55(3):283-90 PMID: 5549896
Article Info
Journal
Molecular and cellular biology
Abbr.
Mol Cell Biol
ISSN
0270-7306
Published
1988-02-00
Pages
963-73
Language
English
Region
United States
NLM ID
8109087
PMCID
PMC363229
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]